Volume 95, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Commercial chikungunya virus (CHIKV)–specific IgM detection kits were evaluated at the Centers for Disease Control and Prevention (CDC), the Public Health Agency of Canada National Microbiology Laboratory, and the Caribbean Public Health Agency (CARPHA). The Euroimmun Anti-CHIKV IgM ELISA kit had ≥ 95% concordance with all three reference laboratory results. The limit of detection for low CHIK IgM+ samples, as measured by serial dilution of seven sera up to 1:12,800 ranged from 1:800 to 1:3,200. The Euroimmun IIFT kit evaluated at CDC and CARPHA performed well, but required more retesting of equivocal results. The InBios CHIKjj MAC-ELISA had 100% and 98% concordance with CDC and CARPHA results, respectively, and had equal sensitivity to the CDC MAC-ELISA to 1:12,800 dilution in serially diluted samples. The Abcam Anti-CHIKV IgM ELISA had high performance at CARPHA, but at CDC, performance was inconsistent between lots. After replacement of the biotinylated IgM antibody controls with serum containing CHIKV-specific IgM and additional quality assurance/control measures, the Abcam kit was rereleased and reevaluated at CDC. The reformatted Abcam kit had 97% concordance with CDC results and limit of detection of 1:800 to 1:3,200. Two rapid tests and three other CHIKV MAC-ELISAs evaluated at CDC had low sensitivity, as the CDC CHIKV IgM in-house positive controls were below the level of detection. In conclusion, laboratories have options for CHIKV serological diagnosis using validated commercial kits.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Powers AM, , 2010. Chikungunya. Clin Lab Med 30: 209219.[Crossref] [Google Scholar]
  2. Powers AM, Roehrig JT, , 2011. Alphaviruses. Methods Mol Biol 665: 1738.[Crossref] [Google Scholar]
  3. Staples JE, Breiman RF, Powers AM, , 2009. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis 49: 942948.[Crossref] [Google Scholar]
  4. Staples JE, Shankar MB, Sejvar JJ, Meltzer MI, Fischer M, , 2014. Initial and long-term costs of patients hospitalized with West Nile virus disease. Am J Trop Med Hyg 90: 402409.[Crossref] [Google Scholar]
  5. Kariuki Njenga M, Nderitu L, Ledermann JP, Ndirangu A, Logue CH, Kelly CH, Sang R, Sergon K, Breiman R, Powers AM, , 2008. Tracking epidemic chikungunya virus into the Indian Ocean from east Africa. J Gen Virol 89: 27542760.[Crossref] [Google Scholar]
  6. Powers AM, Logue CH, , 2007. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 88: 23632377.[Crossref] [Google Scholar]
  7. Sudeep AB, Parashar D, , 2008. Chikungunya: an overview. J Biosci 33: 443449.[Crossref] [Google Scholar]
  8. Cassadou S, Boucau S, Petit-Sinturel M, Huc P, Leparc-Goffart I, Ledrans M, , 2014. Emergence of chikungunya fever on the French side of Saint Martin Island, October to December 2013. Euro Surveill 19: pii20752.[Crossref] [Google Scholar]
  9. Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, de Lamballerie X, , 2014. Chikungunya in the Americas. Lancet 383: 514.[Crossref] [Google Scholar]
  10. Fischer M, Staples JE, Arboviral Diseases Branch, National Center for Emerging, Zoonotic Infectious Diseases, CDC, , 2014. Notes from the field: chikungunya virus spreads in the Americas—Caribbean and South America, 2013–2014. MMWR 63: 500501. [Google Scholar]
  11. Kuno G, , 2015. A re-examination of the history of etiologic confusion between dengue and chikungunya. PLoS Negl Trop Dis 9: e0004101.[Crossref] [Google Scholar]
  12. Sahadeo N, Mohammed H, Allicock OM, Auguste AJ, Widen SG, Badal K, Pulchan K, Foster JE, Weaver SC, Carrington CV, , 2015. Molecular characterisation of chikungunya virus infections in Trinidad and comparison of clinical and laboratory features with dengue and other acute febrile cases. PLoS Negl Trop Dis 9: e0004199.[Crossref] [Google Scholar]
  13. WHO, 2009. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. New edition. Geneva, Switzerland: WHO. [Google Scholar]
  14. Lanciotti RS, Kosoy OL, Laven JJ, Panella AJ, Velez JO, Lambert AJ, Campbell GL, , 2007. Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis 13: 764767.[Crossref] [Google Scholar]
  15. Blacksell SD, Tanganuchitcharnchai A, Jarman RG, Gibbons RV, Paris DH, Bailey MS, Day NP, Premaratna R, Lalloo DG, de Silva HJ, , 2011. Poor diagnostic accuracy of commercial antibody-based assays for the diagnosis of acute chikungunya infection. Clin Vaccine Immunol 18: 17731775.[Crossref] [Google Scholar]
  16. Prat CM, Flusin O, Panella A, Tenebray B, Lanciotti R, Leparc-Goffart I, , 2014. Evaluation of commercially available serologic diagnostic tests for chikungunya virus. Emerg Infect Dis 20: 21292132.[Crossref] [Google Scholar]
  17. Kosasih H, Widjaja S, Surya E, Hadiwijaya SH, Butarbutar DP, Jaya UA, Nurhayati Alisjahbana B, Williams M, , 2012. Evaluation of two IgM rapid immunochromatographic tests during circulation of Asian lineage chikungunya virus. Southeast Asian J Trop Med Public Health 43: 5561. [Google Scholar]
  18. Litzba N, Schuffenecker I, Zeller H, Drosten C, Emmerich P, Charrel R, Kreher P, Niedrig M, , 2008. Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J Virol Methods 149: 175179.[Crossref] [Google Scholar]
  19. Rianthavorn P, Wuttirattanakowit N, Prianantathavorn K, Limpaphayom N, Theamboonlers A, Poovorawan Y, , 2010. Evaluation of a rapid assay for detection of IgM antibodies to chikungunya. Southeast Asian J Trop Med Public Health 41: 9296. [Google Scholar]
  20. Yap G, Pok KY, Lai YL, Hapuarachchi HC, Chow A, Leo YS, Tan LK, Ng LC, , 2010. Evaluation of chikungunya diagnostic assays: differences in sensitivity of serology assays in two independent outbreaks. PLoS Negl Trop Dis 4: e753.[Crossref] [Google Scholar]
  21. Martin DA, Muth DA, Brown T, Johnson AJ, Karabatsos N, Roehrig JT, , 2000. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol 38: 18231826. [Google Scholar]
  22. Beaty B, Calisher C, Shope R, Lennette E, Schmidt N, Lennette D, Lennette E, , 1995. Arboviruses. , eds. Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections. Washington, DC: American Public Health Association, 189212. [Google Scholar]
  23. Johnson BW, Kosoy O, Wang E, Delorey M, Russell B, Bowen RA, Weaver SC, , 2011. Use of sindbis/eastern equine encephalitis chimeric viruses in plaque reduction neutralization tests for arboviral disease diagnostics. Clin Vaccine Immunol 18: 14861491.[Crossref] [Google Scholar]
  24. Johnson AJ, Martin DA, Karabatsos N, Roehrig JT, , 2000. Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol 38: 18271831. [Google Scholar]
  25. Martin DA, Noga A, Kosoy O, Johnson AJ, Petersen LR, Lanciotti RS, , 2004. Evaluation of a diagnostic algorithm using immunoglobulin M enzyme-linked immunosorbent assay to differentiate human West Nile virus and St. Louis encephalitis virus infections during the 2002 West Nile virus epidemic in the United States. Clin Diagn Lab Immunol 11: 11301133. [Google Scholar]
  26. Martin DA, Biggerstaff BJ, Allen B, Johnson AJ, Lanciotti RS, Roehrig JT, , 2002. Use of immunoglobulin M cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol 9: 544549. [Google Scholar]
  27. Pongsiri P, Praianantathavorn K, Theamboonlers A, Payungporn S, Poovorawan Y, , 2012. Multiplex real-time RT-PCR for detecting chikungunya virus and dengue virus. Asian Pac J Trop Med 5: 342346.[Crossref] [Google Scholar]
  28. Clarke DH, Casals J, , 1958. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 7: 561573. [Google Scholar]
  29. Newcombe RG, , 1998. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17: 857872.[Crossref] [Google Scholar]
  30. Wilson E, , 1927. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 22: 209212.[Crossref] [Google Scholar]
  31. Blacksell SD, , 2012. Commercial dengue rapid diagnostic tests for point-of-care application: recent evaluations and future needs? J Biomed Biotechnol 2012: 151967.[Crossref] [Google Scholar]
  32. Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, Enria DA, Pelegrino JL, Vazquez S, Artsob H, Drebot M, Gubler DJ, Halstead SB, Guzman MG, Margolis HS, Nathanson CM, Rizzo Lic NR, Bessoff KE, Kliks S, Peeling RW, , 2009. Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerg Infect Dis 15: 436440.[Crossref] [Google Scholar]
  33. Figueiredo ML, Figueiredo LT, , 2014. Emerging alphaviruses in the Americas: chikungunya and Mayaro. Rev Soc Bras Med Trop 47: 677683.[Crossref] [Google Scholar]
  34. Terzian AC, Auguste AJ, Vedovello D, Ferreira MU, da Silva-Nunes M, Speranca MA, Suzuki RB, Juncansen C, Araujo JP, Jr Weaver SC, Nogueira ML, , 2015. Isolation and characterization of Mayaro virus from a human in Acre, Brazil. Am J Trop Med Hyg 92: 401404.[Crossref] [Google Scholar]
  35. Vieira CJ, Silva DJ, Barreto ES, Siqueira CE, Colombo TE, Ozanic K, Schmidt DJ, Drumond BP, Mondini A, Nogueira ML, Bronzoni RV, , 2015. Detection of Mayaro virus infections during a dengue outbreak in Mato Grosso, Brazil. Acta Trop 147: 1216.[Crossref] [Google Scholar]
  36. Zuchi N, Heinen LB, Santos MA, Pereira FC, Slhessarenko RD, , 2014. Molecular detection of Mayaro virus during a dengue outbreak in the state of Mato Grosso, Central-West Brazil. Mem Inst Oswaldo Cruz 109: 820823.[Crossref] [Google Scholar]
  37. Partidos CD, Paykel J, Weger J, Borland EM, Powers AM, Seymour R, Weaver SC, Stinchcomb DT, Osorio JE, , 2012. Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine. Vaccine 30: 46384643.[Crossref] [Google Scholar]
  38. Powers AM, Brault AC, Tesh RB, Weaver SC, , 2000. Re-emergence of chikungunya and o'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol 81: 471479.[Crossref] [Google Scholar]

Data & Media loading...

  • Received : 05 Jan 2016
  • Accepted : 02 Feb 2016
  • Published online : 06 Jul 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error